Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol for Adipose Tissue Thermogenesis
NCT06319183Phase 1Not yet recruiting
- Sponsor
- Tongji University
- Start
- Mar 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of salbutamol in obesity, sponsored by Tongji University. Primary endpoint: Temperature of Scapular Region at 8 hours. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
salbutamol
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06319183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319183.